Oxford AstraZeneca jabs effective against severe COVID new trial in US confirms Press Trust of India Mar 23, 2021 A large trial in the US and two South American countries of the Oxford-AstraZeneca vaccine has shown 79 per cent efficacy rate at…
Oxford COVID-19 vaccine developer cautious on 2020 roll-out Reuters Jul 22, 2020 The experimental vaccine, which has been licensed to AstraZeneca, produced an immune response in early-stage clinical trials,…
